420 with CNW — Study Links Cannabis to Reduced Pain, Elevated Runner’s High
A recent study has unveiled a fascinating connection between marijuana usage and an enhanced exercise experience, particularly for runners. The study, conducted by researchers at the University of Colorado Boulder, focused on 49 runners. The individuals were asked to evaluate their running experiences under two conditions: one after consuming cannabis and the other without any marijuana intake.
The findings, recently published in the “Cannabis and Cannabinoid Research” journal, revealed that participants had significantly fewer negative emotions and greater feelings of positive affect, dissociation, enjoyment and tranquility during their marijuana-influenced runs compared to their nonmarijuana runs. Furthermore, the intriguing concept of a “runner’s high” was more pronounced when marijuana was involved.
Although the runners’ pace was slightly affected after consuming marijuana, the researchers deemed the decrease of 31 seconds per mile statistically insignificant. Surprisingly, the study revealed that pain levels were lower after the cannabis-influenced runs, while perceived exertion remained unchanged between the two conditions.
The implications of these results point to the possibility that acute marijuana use might contribute to a more gratifying exercise experience for regular marijuana users. Nevertheless, the researchers emphasized the need for further investigations encompassing diverse methodologies, exercise types and populations to ascertain the potential long-term benefits and risks associated with this behavior.
Interestingly, the positive exercise effects of cannabis align with the findings of an earlier study from 2019, which revealed that individuals using marijuana to enhance their workouts tend to engage in a more wholesome amount of physical activity.
In addition, an unrelated study in 2020 demonstrated that older individuals who consumed cannabis were more inclined to participate in physical activities. The study found that older marijuana users had lower BMI at the start of the study, participated in more exercise days and were involved in more exercises during the study period than their noncannabis user counterparts.
Breaking yet another stereotype, a 2021 study highlighted that frequent marijuana users are more likely to be physically active than their nonusing counterparts. This counters the notion that cannabis consumption leads to a sedentary lifestyle.
On another note, the use of medical marijuana has shown significant improvements in the quality of life for individuals with conditions such as insomnia and chronic pain. A 2023 study by the American Medical Association (AMA) found that the positive effects of medical cannabis were sustained over time. Late last year, the AMA also revealed study results linking state legalization of cannabis with a decline in the prescription of opioids to some cancer patients.
These studies attesting to the beneficial and therapeutic effects of cannabis are probably the grounds upon which many companies such as IGC Pharma Inc. (NYSE American: IGC) have focused on developing standardized medicinal formulations from THC and other cannabinoids so that patients can have access to effective cannabis-based treatments which are approved by the FDA.
NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
A recent study has unveiled a fascinating connection between marijuana usage and an enhanced exercise experience, particularly for runners. The study, conducted by researchers at the University of Colorado Boulder, focused on 49 runners. The individuals were asked to evaluate their running experiences under two conditions: one after consuming cannabis and the other without any marijuana intake.
The findings, recently published in the “Cannabis and Cannabinoid Research” journal, revealed that participants had significantly fewer negative emotions and greater feelings of positive affect, dissociation, enjoyment and tranquility during their marijuana-influenced runs compared to their nonmarijuana runs. Furthermore, the intriguing concept of a “runner’s high” was more pronounced when marijuana was involved.
Although the runners’ pace was slightly affected after consuming marijuana, the researchers deemed the decrease of 31 seconds per mile statistically insignificant. Surprisingly, the study revealed that pain levels were lower after the cannabis-influenced runs, while perceived exertion remained unchanged between the two conditions.
The implications of these results point to the possibility that acute marijuana use might contribute to a more gratifying exercise experience for regular marijuana users. Nevertheless, the researchers emphasized the need for further investigations encompassing diverse methodologies, exercise types and populations to ascertain the potential long-term benefits and risks associated with this behavior.
Interestingly, the positive exercise effects of cannabis align with the findings of an earlier study from 2019, which revealed that individuals using marijuana to enhance their workouts tend to engage in a more wholesome amount of physical activity.
In addition, an unrelated study in 2020 demonstrated that older individuals who consumed cannabis were more inclined to participate in physical activities. The study found that older marijuana users had lower BMI at the start of the study, participated in more exercise days and were involved in more exercises during the study period than their noncannabis user counterparts.
Breaking yet another stereotype, a 2021 study highlighted that frequent marijuana users are more likely to be physically active than their nonusing counterparts. This counters the notion that cannabis consumption leads to a sedentary lifestyle.
On another note, the use of medical marijuana has shown significant improvements in the quality of life for individuals with conditions such as insomnia and chronic pain. A 2023 study by the American Medical Association (AMA) found that the positive effects of medical cannabis were sustained over time. Late last year, the AMA also revealed study results linking state legalization of cannabis with a decline in the prescription of opioids to some cancer patients.
These studies attesting to the beneficial and therapeutic effects of cannabis are probably the grounds upon which many companies such as IGC Pharma Inc. (NYSE American: IGC) have focused on developing standardized medicinal formulations from THC and other cannabinoids so that patients can have access to effective cannabis-based treatments which are approved by the FDA.
NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
